Shield Therapeutics reports 2.8x revenue growth in FY23, driven by increasing adoption of Accrufer in the US. The company also highlights significant operational progress, including a paediatric study and ongoing expansion into Canada, China, and Korea.
England expects it could be a tricky night for Rishi Sunak – can he survive until the General Election? And will the Tory party survive in the long run? Helen Thomas, former advisor to George Osborne, is here to discuss.
Essentially Group successfully wraps up acquisition of Best of Latin Foodstuff Trading LLC and appoints Catalina Oñate as Executive Director.
Polarean Imaging secures a major new order for its Xenon MRI System from the University of Alabama at Birmingham (UAB) Hospital, marking its second de novo acquisition in the US. POLX shares jumped 44% on the news.
88 Energy ramps up exploration of its PEL 93 acreage in onshore Namibia with the award of a 2D seismic contract, aiming to validate leads and pursue a maiden resource declaration in the Owambo Basin.
On Todays Exchange we are planning to cover a number of 'popular' companies such as Avacta , XP Factory, Cornerstone FS, Journeo, Loungers & many others.
Light Science Technologies expands its Controlled Environment Agriculture division's market reach by partnering with AgriLogiq for exclusive distribution in South Africa, tapping into the region's burgeoning agricultural market.
Strategic Minerals advances its Redmoor Copper-Tungsten-Tin project in Cornwall with extensive core re-logging and sampling, while initiating promising recon exploration in the newly acquired Tamar Valley license area.
Vox Markets speaks to Simon Deacon, CEO of Light Science Technologies (LST), about a year which has seen rapid revenue growth and judicious cost management move the controlled environment agriculture and passive fire protection specialist move close to self-financing growth as it eyes global expansion.
Cornerstone FS, trading as Finseta, announces a stellar 100% revenue surge to £9.6m and first-ever profitability, bolstered by an expansion of its global payments network and securing regulatory approval in Canada.
XP Factory's Q1 results showcase substantial double-digit growth, driven by strong performance in both Escape Hunt and Boom Battle Bar brands, aligning with market projections for the fiscal year ending March 31, 2024.
Polarean Imaging will showcase its novel Xenon MRI technology at the ATS 2024 Respiratory Innovation Summit, highlighting advancements in lung imaging and fostering partnerships within the pulmonary medicine community.
In this interview, CEO James Hickman and CFO Judy Happe of Cornerstone FS (soon to be renamed as Finseta) take me through today's excellent FY23 results - reporting adjusted EBITDA of £1.7m on sales up 100% LFL to £9.6m
Eden Research unveils 78% revenue growth and key product milestones in its FY23 preliminary results, driven by the launch of its seed treatment Ecovelex and expanded regulatory approvals for flagship biopesticides.
Frontier Developments expects FY24 revenue to exceed £85m with an improved adjusted EBITDA, buoyed by robust game sales and strategic restructuring efforts.
Atlantic Lithium continues to highlight the strengths of Ewoyaa as a developing lithium project. These latest results show the potential for meaningful upgrades to the resource later in the year. Not surprisingly, the shares rose by more than 5% on the news.
Prospex Energy reports steady Q1 production from its PM-1 gas facility at Selva field, Italy, at ~80,000 scm/d. Gross Q1 revenue was €1.91m from PXEN's 18-month offtake agreement with BP Gas Marketing.
Polarean Imaging fulfills an order from Cincinnati Children's Hospital for an upgraded hyperpolariser, enabling it to leverage the benefits of Polarean's XENOVIEW MRI technology in its research programme.
Atlantic Lithium Limited (ALL) has secured approval to list its shares on the Ghana Stock Exchange (GSE), becoming the first near-term lithium producer with an in-country asset to do so.
Metals One's farm-in agreement with Gunsynd is moving along, with the second payment now due. The cash injection will accelerate the development of MET1's highly prospective Black Schist project where the Rautavaara licence hosts a range of critical battery metals.